Search research articles
Contact Us
Filters
Showing results (201-210 of 225) with videos related to
Page
of 23
Sort By:
Blood
|
September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
Lorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2016
Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
Wolfgang Wick, Thierry Gorlia, Pierre Bady, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 28, 2025
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort
Giulio Disanto, Sabine Schaedelin, Johanna Oechtering, et al.
Acta Neuropathologica
|
June 27, 2023
A T-cell antigen atlas for meningioma: novel options for immunotherapy
Gioele Medici, Lena K Freudenmann, Julia Velz, et al.
Oncotarget
|
November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic glioma
Maximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
Neuro-Oncology
|
April 14, 2022
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
Antonio Omuro, Alba A Brandes, Antoine F Carpentier, et al.
Neuro-Oncology
|
March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
Patrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Neurology. Clinical Practice
|
July 7, 2025
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort
Maximilian Einsiedler, Chiara Zecca, Lisa Hofer, et al.
Journal of Neurology
|
July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort
Alessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
The Oncologist
|
January 22, 2026
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis
Ogechukwu A Asogwa, Linda Dirven, Neil K Aaronson, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 225) with videos related to
Sort By:
Page
of 23
Blood
|
September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
Lorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2016
Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
Wolfgang Wick, Thierry Gorlia, Pierre Bady, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 28, 2025
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort
Giulio Disanto, Sabine Schaedelin, Johanna Oechtering, et al.
Acta Neuropathologica
|
June 27, 2023
A T-cell antigen atlas for meningioma: novel options for immunotherapy
Gioele Medici, Lena K Freudenmann, Julia Velz, et al.
Oncotarget
|
November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic glioma
Maximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
Neuro-Oncology
|
April 14, 2022
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
Antonio Omuro, Alba A Brandes, Antoine F Carpentier, et al.
Neuro-Oncology
|
March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial
Patrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Neurology. Clinical Practice
|
July 7, 2025
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort
Maximilian Einsiedler, Chiara Zecca, Lisa Hofer, et al.
Journal of Neurology
|
July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort
Alessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
The Oncologist
|
January 22, 2026
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis
Ogechukwu A Asogwa, Linda Dirven, Neil K Aaronson, et al.
Page
of 23